Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Amicus Therapeutics, Inc. - Common Stock (NQ:FOLD)

14.34 -0.02 (-0.14%)

Streaming Delayed Price Updated: 4:00 PM EST, Mar 3, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	4,590,797
Open	14.34
Bid (Size)	14.34 (300)
Ask (Size)	14.36 (100)
Prev. Close	14.36
Today's Range	14.34 - 14.35
52wk Range	5.510 - 14.38
Shares Outstanding	266,555,274
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing ↗

Today 10:11 EST

PTC Therapeutics develops therapies for rare diseases, with a portfolio spanning commercial products and investigational candidates.

Via The Motley Fool

Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing ↗

March 02, 2026

This clinical-stage biotech develops therapies for rare muscle diseases using its proprietary FORCE platform and research-driven approach.

Via The Motley Fool

Performance

YTD	+0.5%	+0.5%
1 Month	+0.3%	+0.3%
3 Month	+47.4%	+47.4%
6 Month	+82.0%	+82.0%
1 Year	+57.1%	+57.1%

More News

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing ↗

March 02, 2026

Via The Motley Fool

Amicus Stock Surges To Near 2-Year Highs On BioMarin's $4.8B Buyout Deal ↗

December 19, 2025

Via Stocktwits

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

February 20, 2026

From Amicus Therapeutics, Inc.

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether RAPT, CTGO, TBN, FOLD are Obtaining Fair Deals for their Shareholders

February 19, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Amicus Therapeutics Presents New Long-term Data for both Galafold® (migalastat) and POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at the 22nd Annual WORLDSymposium™ 2026

February 03, 2026

From Amicus Therapeutics, Inc.

Via GlobeNewswire

Halper Sadeh LLC Reminds Shareholders of JHG, FOLD, RAPT of the Firm’s Investigations

February 02, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Should You Buy BioMarin Pharmaceutical Before Feb. 18? ↗

January 31, 2026

Via The Motley Fool

FOLD Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Amicus Therapeutics, Inc. is Fair to Shareholders

January 23, 2026

From Halper Sadeh LLC

Via Business Wire

Halper Sadeh LLC Encourages PEN, FOLD, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights

January 22, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG Shareholders to Contact the Firm to Discuss Their Rights

January 07, 2026

From Halper Sadeh LLC

Via GlobeNewswire

The Great Unlocking: 2026 Opens with a Historic Surge in Large-Cap M&A Activity

January 06, 2026

Via MarketMinute

Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG Shareholders to Contact the Firm to Discuss Their Rights

January 06, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BioMarin’s $4.8 Billion Amicus Acquisition: A Strategic Pivot to Rare Disease Dominance

January 02, 2026

Via MarketMinute

Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal

December 29, 2025

Via MarketMinute

Amicus Therapeutics Investment Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amicus Therapeutics, Inc. - FOLD

December 26, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

The Liquidity Vacuum: Thin Holiday Trading Sparks Volatility as 2025 Draws to a Close

December 26, 2025

Via MarketMinute

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Clearwater Analytics Holdings, Inc. (NYSE - CWAN), Katapult Holdings, Inc. (Nasdaq - KPLT), Janus Henderson Group plc (NYSE - JHG), Amicus Therapeutics, Inc. (Nasdaq

December 23, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Unusual volume stocks in Tuesday's session ↗

December 23, 2025

Via Chartmill

Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights

December 20, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

December 19, 2025

Via Chartmill

Discover the most active stocks in Friday's session. ↗

December 19, 2025

Via Chartmill

Which stocks are moving on Friday? ↗

December 19, 2025

Via Chartmill

Which stocks are gapping on Friday? ↗

December 19, 2025

Via Chartmill

Frequently Asked Questions

Is Amicus Therapeutics, Inc. - Common Stock publicly traded?

Yes, Amicus Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Amicus Therapeutics, Inc. - Common Stock trade on?

Amicus Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Amicus Therapeutics, Inc. - Common Stock?

The ticker symbol for Amicus Therapeutics, Inc. - Common Stock is FOLD on the Nasdaq Stock Market

What is the current price of Amicus Therapeutics, Inc. - Common Stock?

The current price of Amicus Therapeutics, Inc. - Common Stock is 14.34

When was Amicus Therapeutics, Inc. - Common Stock last traded?

The last trade of Amicus Therapeutics, Inc. - Common Stock was at 03/03/26 04:00 PM ET

What is the market capitalization of Amicus Therapeutics, Inc. - Common Stock?

The market capitalization of Amicus Therapeutics, Inc. - Common Stock is 3.82B

How many shares of Amicus Therapeutics, Inc. - Common Stock are outstanding?

Amicus Therapeutics, Inc. - Common Stock has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.